POINT-OF-CARE CYP2C19 GENOTYPE GUIDED ANTIPLATELET THERAPY IN CARDIAC CATHETERIZATION LABORATORY AND CLINICAL OUTCOMES AFTER PCI

Paul A. Gurbel,Kevin Bliden,Matthew Sherwood,Shahram Yazdani,Hamid Taheri,Alexander Truesdell,Marjaneh Akbari,Kelly Epps,Udaya Tantry

Journal of the American College of Cardiology（2019）

引用 1|浏览45

暂无评分

摘要

CYP2C19 polymorphisms affect clopidogrel metabolism and clinical outcomes in patients undergoing percutaneous coronary intervention (PCI). The use of a point-of-care (POC) assay to routinely genotype patients immediately prior to PCI in a hospital cardiac catheterization lab has shown to be feasible

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要